13F filer · CIK 1513038 ↗
Perkins Coie Trust Co
You are looking at Q2 2022. See the latest, Q3 2026 →
Reported value
$274.7M
−15% on the quarter before
Positions
262
6 new · 9 sold out
Top 10
37.7%
of the value
Est. gain
−$49.6M
on stocks held all quarter
Est. return
−15.6%
on those stocks since Q1 2022
Positions as of Jun 30, 2022, from Perkins Coie Trust Co's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 61% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2022. Striped tiles are options.
Largest buys
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Vanguard Mid Cap ETF~$1.4MAdded · 6.9% → 7.2%+6,884 shares
- Vanguard Russell 1000 Growth ETF~$427,299Added · 3.5% → 3.4%+7,594 shares
- Alphabet~$274,565Added · 2.3% → 2.2%+126 shares
- Target Corp~$257,329Added · 1.0% → 0.9%+1,822 shares
- Cisco~$204,536Added · 1.6% → 1.5%+4,798 shares
- Freeport-McMoRan~$203,817Added · 0.1% → 0.2%+6,973 shares
- Us Bancorp~$200,054Added · 0.0% → 0.1%+4,349 shares
- Qualcomm~$199,132Added · 2.0% → 2.1%+1,559 shares
- Marriott International Inc~$179,721Added · 0.1% → 0.1%+1,322 shares
- Walt Disney Company (The)~$153,026Added · 1.4% → 1.2%+1,621 shares
Largest sells
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Vanguard Mid Cap ETF~$849,316Cut · 2.9% → 2.5%−4,312 shares
- Ishares S&P 500 Growth ETF~$441,443Cut · 4.5% → 4.0%−7,315 shares
- Nike Inc Cl B~$256,488Cut · 0.4% → 0.2%−2,510 shares
- Microsoft~$207,771Cut · 6.5% → 6.3%−809 shares
- Bentley Systems~$166,440Cut · 1.1% → 0.9%−5,000 shares
- Ishares S&P Midcap 400 Growth~$94,173Cut · 1.5% → 1.4%−1,478 shares
- Sherwin-Williams Co~$79,000Sold out · 0.0% → 0.0%−318 shares
- Nuveen Muni Credit Income Fd~$72,826Cut · 0.2% → 0.2%−5,796 shares
- Nuveen Amt Free Muni Credit Income Fd~$71,803Cut · 0.2% → 0.2%−5,475 shares
- Danaher Corp~$66,166Cut · 2.2% → 2.2%−261 shares
Holdings
As of Jun 30, 2022. Changes are in shares against Mar 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vanguard Mid Cap ETFEQUITY - MIDCAP - ETF · shares +7.3% · price −17.2% | 7.2% | $19.8M | −$3.8M | ||||||||
| MicrosoftCOMMON STOCK · shares −1.2% · price −16.7% | 6.3% | $17.3M | −$3.5M | ||||||||
| AppleCOMMON STOCK · shares −0.1% · price −21.7% | 5.1% | $14.1M | −$3.9M | ||||||||
| Ishares S&P 500 Growth ETFEQUITY - LARGE CAP - ETF · shares −3.9% · price −21.0% | 4.0% | $10.9M | −$2.9M | ||||||||
| Vanguard Russell 1000 Growth ETFEQUITY - LARGE CAP - ETF · shares +4.8% · price −21.1% | 3.4% | $9.3M | −$2.4M | ||||||||
| Unitedhealth Group IncCOMMON STOCK · shares +0.4% · price +0.7% | 2.6% | $7.2M | +$50,752 | ||||||||
| Vanguard Mid Cap ETFEQUITY - MIDCAP - ETF · shares −11% · price −17.2% | 2.5% | $6.8M | −$1.4M | ||||||||
| AlphabetCOMMON STOCK · shares +4.7% · price −21.6% | 2.2% | $6.2M | −$1.6M | ||||||||
| Danaher CorpCOMMON STOCK · shares −1.1% · price −13.6% | 2.2% | $6.2M | −$966,448 | ||||||||
| Visa Inc.COMMON STOCK · shares +2.5% · price −11.2% | 2.2% | $6.0M | −$742,503 | ||||||||
| Procter & Gamble CoCOMMON STOCK · shares −0.2% · price −5.9% | 2.1% | $5.8M | −$364,483 | ||||||||
| Pepsico IncCOMMON STOCK · shares +0.3% · price −0.4% | 2.1% | $5.8M | −$24,167 | ||||||||
| QualcommCOMMON STOCK · shares +3.7% · price −16.4% | 2.1% | $5.6M | −$1.1M | ||||||||
| Home Depot IncCOMMON STOCK · shares +1.1% · price −8.4% | 2.0% | $5.6M | −$506,436 | ||||||||
| Pfizer IncCOMMON STOCK · shares +1.0% · price +1.3% | 1.6% | $4.5M | +$56,009 | ||||||||
| Charles Schwab CorpCOMMON STOCK · shares +0.6% · price −25.1% | 1.5% | $4.2M | −$1.4M | ||||||||
| OracleCOMMON STOCK · shares +3.0% · price −15.6% | 1.5% | $4.2M | −$750,294 | ||||||||
| Accenture PlcCOMMON STOCK · shares +2.9% · price −17.7% | 1.5% | $4.2M | −$872,671 | ||||||||
| American TowerCOMMON STOCK · shares +1.7% · price +1.7% | 1.5% | $4.2M | +$70,224 | ||||||||
| CiscoCOMMON STOCK · shares +5.2% · price −23.5% | 1.5% | $4.2M | −$1.2M | ||||||||
| Utilities Select Sector SPDR ETFEQUITY SECTOR - ETF · shares +3.0% · price −5.8% | 1.5% | $4.1M | −$247,047 | ||||||||
| Abbvie IncCOMMON STOCK · shares −0.7% · price −5.5% | 1.5% | $4.1M | −$241,523 | ||||||||
| BlackRockCOMMON STOCK · shares +3.2% · price −20.3% | 1.5% | $4.1M | −$1.0M | ||||||||
| Cvs Health CorpCOMMON STOCK · shares +2.0% · price −8.5% | 1.5% | $4.1M | −$372,400 | ||||||||
| Starbucks CorpCOMMON STOCK · shares +3.3% · price −16.0% | 1.4% | $3.9M | −$727,253 | ||||||||
| Total · 262 positions | 100% | $274.7M | −$49.6M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2022 to Q2 2022: 251 stocks held throughout, down $49.6M (−15.6%).
- IBM+$202,676+9%
- American Tower+$70,224+2%
- Pfizer Inc+$56,009+1%
- Merck & Co Inc+$51,000+11%
- Unitedhealth Group Inc+$50,752+1%
- Vanguard Russell 1000 Growth ETF−$2.4M−21%
- Ishares S&P 500 Growth ETF−$2.9M−21%
- Microsoft−$3.5M−17%
- Vanguard Mid Cap ETF−$3.8M−17%
- Apple−$3.9M−22%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 14, 2026 | $625.7M+4% | SEC ↗ |
| Q2 2026 | Jul 9, 2026 | $603.3M+16% | SEC ↗ |
| Q1 2026 | Apr 15, 2026 | $520.1M−3% | SEC ↗ |
| Q4 2025 | Jan 12, 2026 | $537.0M+1% | SEC ↗ |
| Q3 2025 | Oct 9, 2025 | $531.5M−9% | SEC ↗ |
| Q2 2025 | Jul 10, 2025 | $587.1M+33% | SEC ↗ |
| Q1 2025 | Apr 11, 2025 | $441.0M−3% | SEC ↗ |
| Q4 2024 | Jan 16, 2025 | $454.4M+1% | SEC ↗ |
| Q3 2024 | Oct 8, 2024 | $450.9M+5% | SEC ↗ |
| Q2 2024 | Jul 15, 2024 | $430.1M+1% | SEC ↗ |
| Q1 2024 | Apr 12, 2024 | $426.7M+8% | SEC ↗ |
| Q4 2023 | Jan 9, 2024 | $396.1M+12% | SEC ↗ |
| Q3 2023 | Oct 11, 2023 | $354.4M+1% | SEC ↗ |
| Q2 2023 | Jul 14, 2023 | $352.1M+5% | SEC ↗ |
| Q1 2023 | Apr 13, 2023 | $333.8M+7% | SEC ↗ |
| Q4 2022 | Jan 18, 2023 | $312.8M+20% | SEC ↗ |
| Q3 2022 | Oct 7, 2022 | $260.9M−5% | SEC ↗ |
| Q2 2022 | Jul 8, 2022 | $274.7M−15% | SEC ↗ |
| Q1 2022 | Apr 15, 2022 | $322.1M−6% | SEC ↗ |
| Q4 2021 | Jan 13, 2022 | $341.1M+7% | SEC ↗ |
| Q3 2021 | Oct 13, 2021 | $319.7M−2% | SEC ↗ |
| Q2 2021 | Jul 14, 2021 | $324.9M+8% | SEC ↗ |
| Q1 2021 | Apr 13, 2021 | $300.0M+2% | SEC ↗ |
| Q4 2020 | Jan 12, 2021 | $293.0M+17% | SEC ↗ |
| Q3 2020 | Oct 13, 2020 | $250.5M+3% | SEC ↗ |
| Q2 2020 | Jul 13, 2020 | $243.1M+24% | SEC ↗ |
| Q1 2020 | Apr 10, 2020 | $196.4M−20% | SEC ↗ |
| Q4 2019 | Jan 9, 2020 | $244.1M+8% | SEC ↗ |
| Q3 2019 | Oct 11, 2019 | $225.8M+3% | SEC ↗ |
| Q2 2019 | Jul 10, 2019 | $220.1M+2% | SEC ↗ |
| Q1 2019 | Apr 8, 2019 | $215.0M+13% | SEC ↗ |
| Q4 2018 | Jan 15, 2019 | $191.0M−11% | SEC ↗ |
| Q3 2018 | Oct 15, 2018 | $215.4M+6% | SEC ↗ |
| Q2 2018 | Jul 17, 2018 | $202.3M+0% | SEC ↗ |
| Q1 2018 | Apr 16, 2018 | $201.4M+1% | SEC ↗ |
| Q4 2017 | Jan 12, 2018 | $200.2M+4% | SEC ↗ |
| Q3 2017 | Oct 13, 2017 | $192.6M+4% | SEC ↗ |
| Q2 2017 | Jul 10, 2017 | $185.8M+9% | SEC ↗ |
| Q1 2017 | Apr 11, 2017 | $170.1M+3% | SEC ↗ |
| Q4 2016 | Jan 10, 2017 | $164.8M+5% | SEC ↗ |
| Q3 2016 | Oct 11, 2016 | $157.7M+4% | SEC ↗ |
| Q2 2016 | Jul 8, 2016 | $151.6M+3% | SEC ↗ |
| Q1 2016 | Apr 15, 2016 | $147.0M | SEC ↗ |